Compare · SNN vs WMGI
SNN vs WMGI
Side-by-side comparison of Smith & Nephew SNATS Inc. (SNN) and Wright Medical Group N.V. (WMGI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SNN and WMGI operate in Industrial Specialties (Health Care), so they compete in similar markets.
- SNN carries a market cap of $13.41B.
- SNN has hit the wire 6 times in the past 4 weeks while WMGI has been quiet.
- SNN has more recent analyst coverage (22 ratings vs 0 for WMGI).
- Company
- Smith & Nephew SNATS Inc.
- Wright Medical Group N.V.
- Price
- $31.57-1.16%
- -
- Market cap
- $13.41B
- -
- 1M return
- -2.70%
- -
- 1Y return
- +18.02%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- 2011
- News (4w)
- 6
- 0
- Recent ratings
- 22
- 0
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest SNN
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- New data for Smith+Nephew's CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Amendment: SEC Form 6-K/A filed by Smith & Nephew SNATS Inc.
- Smith+Nephew's REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,*
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
Latest WMGI
- Wright Medical Announces Fundamental Change With Respect to the 2.25% Cash Convertible Senior Notes due 2021 issued by Wright Medical Group N.V. and the 1.625% Cash Exchangeable Senior Notes due 2023 issued by Wright Medical Group, Inc.
- Stryker completes acquisition of Wright Medical
- Stryker announces intention to complete acquisition of Wright Medical
- Stryker announces receipt of all required regulatory approvals for proposed acquisition of Wright Medical
- Stryker extends cash tender offer for all outstanding shares of Wright Medical
- Stryker extends cash tender offer for all outstanding shares of Wright Medical